Search Results - "Berns, Jeffrey S."

Refine Results
  1. 1

    The Renal Manifestations of Thyroid Disease by MARIANI, Laura H, BERNS, Jeffrey S

    “…Thyroid hormones influence renal development, kidney structure, renal hemodynamics, GFR, the function of many transport systems along the nephron, and sodium…”
    Get full text
    Journal Article
  2. 2

    A Survey-Based Evaluation of Self-Perceived Competency after Nephrology Fellowship Training by Berns, Jeffrey S

    “…There have been no recent analyses of the adequacy of training in U.S. nephrology training programs or the importance of specific aspects of fellowship…”
    Get full text
    Journal Article
  3. 3

    Effects of Molidustat in the Treatment of Anemia in CKD by Macdougall, Iain C, Akizawa, Tadao, Berns, Jeffrey S, Bernhardt, Thomas, Krueger, Thilo

    “…The efficacy and safety of molidustat, a hypoxia-inducible factor-prolyl hydroxylase inhibitor, have been evaluated in three 16-week, phase 2b studies in…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Onco-Nephrology: Tumor Lysis Syndrome by Wilson, F Perry, Berns, Jeffrey S

    “…Tumor lysis syndrome (TLS) describes the clinical and laboratory sequelae that result from the rapid release of intracellular contents of dying cancer cells…”
    Get full text
    Journal Article
  7. 7

    False-Positive Rate of AKI Using Consensus Creatinine-Based Criteria by Lin, Jennie, Fernandez, Hilda, Shashaty, Michael G S, Negoianu, Dan, Testani, Jeffrey M, Berns, Jeffrey S, Parikh, Chirag R, Wilson, F Perry

    “…Use of small changes in serum creatinine to diagnose AKI allows for earlier detection but may increase diagnostic false-positive rates because of inherent…”
    Get full text
    Journal Article
  8. 8

    Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies by Akizawa, Tadao, Macdougall, Iain C, Berns, Jeffrey S, Bernhardt, Thomas, Staedtler, Gerald, Taguchi, Megumi, Iekushi, Kazuma, Krueger, Thilo

    Published in American journal of nephrology (01-04-2019)
    “…Molidustat, a novel hypoxia-inducible factor-prolyl hydroxylase inhibitor, is being investigated for the treatment of anemia associated with chronic kidney…”
    Get more information
    Journal Article
  9. 9

    Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease by Bahrainwala, Jehan, MD, Berns, Jeffrey S., MD

    Published in Seminars in nephrology (01-03-2016)
    “…Summary Anemia is a common and clinically important consequence of chronic kidney disease (CKD). It is most commonly a result of decreased erythropoietin…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    25-Hydroxyvitamin D Testing and Supplementation in CKD: An NKF-KDOQI Controversies Report by Kramer, Holly, MD, MPH, Berns, Jeffrey S., MD, Choi, Michael J., MD, Martin, Kevin, MD, Rocco, Michael V., MD

    Published in American journal of kidney diseases (01-10-2014)
    “…The benefits of and thresholds for 25-hydroxyvitamin D administration in individuals with chronic kidney disease (CKD) remain uncertain. In this report,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Erythropoietin and Resistant Hypertension in CKD by Boyle, Suzanne M., MD, Berns, Jeffrey S., MD

    Published in Seminars in nephrology (01-09-2014)
    “…Summary There is a well-documented association between erythropoiesis-stimulating agents (ESAs) and hypertension in chronic kidney disease. Studies suggest…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Performance of Procedures by Nephrologists and Nephrology Fellows at U.S. Nephrology Training Programs by Berns, Jeffrey S, O'Neill, W Charles

    “…Some procedures (e.g., placement of temporary hemodialysis catheters and kidney biopsies) are required in nephrology fellowship training. Others (e.g.,…”
    Get full text
    Journal Article
  20. 20

    Dabigatran and Kidney Disease: A Bad Combination by Knauf, Felix, Chaknos, C Michael, Berns, Jeffrey S, Perazella, Mark A

    “…Dabigatran is an oral direct thrombin inhibitor widely used to prevent and treat various thromboembolic complications. An advantage of this agent over other…”
    Get full text
    Journal Article